These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of prostatic carcinoma from the endocrinologic viewpoint]. Rothauge CF; Wildberger JE; Szasz G; Graef V Urologe; 1969; 8(5):237-9. PubMed ID: 5359388 [No Abstract] [Full Text] [Related]
23. Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase. Akimoto S; Inomiya H; Akakura K; Shimazaki J; Ito H Jpn J Clin Oncol; 1997 Aug; 27(4):258-62. PubMed ID: 9379515 [TBL] [Abstract][Full Text] [Related]
24. O,P'DDD IN THE TREATMENT OF ADVANCED MAMMARY CARCINOMA. WEISENFELD S; HECHT A; LEICHTER D; GOLDNER M Cancer; 1964 Oct; 17():1258-66. PubMed ID: 14236758 [No Abstract] [Full Text] [Related]
25. [COMPARATIVE INVESTIGATION OF THE DIFFERENT SERO-HUMORAL CHANGES IN CARCINOMA OF THE PROSTATE. EFFECTS INDUCED BY THE ADMINISTRATION OF ESTROGENS]. STRADAJOLI G; GALLIVANONE A Arch Ital Urol; 1963 Dec; 36():275-85. PubMed ID: 14114462 [No Abstract] [Full Text] [Related]
26. Twin Cities--the highest incidence of prostatic cancer in the nation. Godec CJ; Bates H; Fencl RJ; Cass AS Minn Med; 1982 Oct; 65(10):611-5. PubMed ID: 6757700 [No Abstract] [Full Text] [Related]
27. [In the treatment of cancer of the prostate, is the association of castration with estrogens justified?]. TISSOT J; BOUVART D Prog Med (Paris); 1960 Jan; 88():3-11. PubMed ID: 13838510 [No Abstract] [Full Text] [Related]
28. HISTOCHEMISTRY OF THE NORMAL, HYPERPLASTIC, AND NEOPLASTIC HUMAN PROSTATE GLAND. KIRCHHEIM D; GYOERKEY F; BRANDES D; SCOTT WW Invest Urol; 1964 Jan; 1():403-21. PubMed ID: 14113099 [No Abstract] [Full Text] [Related]
29. [Rate of survival in prostatic cancer with bone metastasis]. Kuntz D; Ryckewaert A Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263 [No Abstract] [Full Text] [Related]
30. A SEARCH FOR INHIBITORS OF PROSTATE GROWTH STIMULATORS. TESAR C; SCOTT WW Invest Urol; 1964 Mar; 1():482-98. PubMed ID: 14130592 [No Abstract] [Full Text] [Related]
31. SELF-CASTRATION BY A MAN WITH CYCLIC CHANGES IN SEXUALITY. SCHNEIDER SF; HARRISON SI; SIEGEL BL Psychosom Med; 1965; 27():53-70. PubMed ID: 14258697 [No Abstract] [Full Text] [Related]
33. [Results of combined therapy of prostate cancer; orchiectomy with estrogens]. HOLDER E Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1953; 275(3-4):178-90. PubMed ID: 13098150 [No Abstract] [Full Text] [Related]
34. Orchiectomy for advanced prostatic carcinoma. A reevaluation. Blackard CE; Byar DP; Jordan WP Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820 [No Abstract] [Full Text] [Related]
35. [CYTOLOGICAL STUDIES ON HORMONAL ACTION IN THE TREATMENT OF PROSTATIC CARCINOMA]. BUCHBERGER HG; BAUCHWITZ MA Z Urol; 1963; 56():411-20. PubMed ID: 14086382 [No Abstract] [Full Text] [Related]
36. [DETERMINATION OF PLASMA TESTOSTERONE IN ANORCHID SUBJECTS. CONSIDERATIONS ON THE ORIGIN AND SIGNIFICANCE OF URINARY ANDROGEN CATABOLITES]. SORCINI G; DILORENZO M; SCIARRA F; LOTTI P; CIAMPALINI L Folia Endocrinol; 1963 Oct; 16():495-9. PubMed ID: 14114703 [No Abstract] [Full Text] [Related]
37. Metastatic breast carcinoma of prostatic origin. Lome LG; Austen G Am J Surg; 1970 Jul; 120(1):113-5. PubMed ID: 4193445 [No Abstract] [Full Text] [Related]
39. [Comparative study of the thyroid activity of the normal or castrated drake, or the drake maintained in permanent darkness. II. Period of seasonal sexual rest]. TIXIER-VIDAL A; ASSENMACHER I C R Seances Soc Biol Fil; 1961; 155():286-90. PubMed ID: 13777083 [No Abstract] [Full Text] [Related]
40. [Hormone therapy and orchiectomy in cancer of the prostate; two cases with prolonged evolution]. VICCHI M Rev Argent Urol; 1952; 21(1-6):55-68. PubMed ID: 13047681 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]